Loading…
Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study
Background Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe. Results Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from...
Saved in:
Published in: | Cancer nanotechnology 2023-12, Vol.14 (1), p.6-17, Article 6 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33 |
---|---|
cites | cdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33 |
container_end_page | 17 |
container_issue | 1 |
container_start_page | 6 |
container_title | Cancer nanotechnology |
container_volume | 14 |
creator | Swidan, Mohamed M. Essa, Basma M. Sakr, Tamer M. |
description | Background
Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe.
Results
Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior.
Conclusions
In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively. |
doi_str_mv | 10.1186/s12645-023-00157-y |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_968515f73be346a0ad74aca565bcc1f3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_968515f73be346a0ad74aca565bcc1f3</doaj_id><sourcerecordid>2771822026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhSMEElXpC7CyxDpc_yROzA5VQCtVogtYW3Ptceqr1L7YzoX0MXhi3AaVHd6MNT7nm5FP07xl9D1jo9xlxmXXt5SLllLWD-36ojmrD2MrlZQvn-_9-Lq5yPlA6xFKKarOmt-3yefiA-5cnKFg65Zgio8BZv-AlkwJjncYkMRf3iKBTMrPSHwoyYfsDczzShJYH320PlSAJQFCbMsdplor2uQPJOPsdnaBuTrJyZ8iKZAmrHMnYuL9ERIUf0KSy2LXN80rB3PGi7_1vPn--dO3y6v25uuX68uPN60RvSqtACaNQqsGoToLIzjqOuHcSJVg46CoFGYvELjplVSd7KhhY8eBchiQgxDnzfXGtREO-pj8PaRVR_D6qRHTpCHV_WfUSo49690g9ig6CRTs0IGBXvZ7Y5h7ZL3bWMcUfyyYiz7EJdVPzJoPAxs5p1xWFd9UJsWcE7rnqYzqxyj1FqWuUeqnKPVaTWIz5SoOE6Z_6P-4_gAjGKWL</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2771822026</pqid></control><display><type>article</type><title>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</title><source>Publicly Available Content Database</source><source>Springer Nature - SpringerLink Journals - Fully Open Access</source><creator>Swidan, Mohamed M. ; Essa, Basma M. ; Sakr, Tamer M.</creator><creatorcontrib>Swidan, Mohamed M. ; Essa, Basma M. ; Sakr, Tamer M.</creatorcontrib><description>Background
Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe.
Results
Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior.
Conclusions
In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively.</description><identifier>ISSN: 1868-6958</identifier><identifier>EISSN: 1868-6966</identifier><identifier>DOI: 10.1186/s12645-023-00157-y</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Biochemistry ; Biocompatibility ; Biomedical Engineering and Bioengineering ; Cancer Research ; Cerium gadolinium oxides ; Chemistry and Materials Science ; Comparative studies ; Folic acid ; Graphene ; Graphene oxide nanosheets ; In vivo methods and tests ; Intrinsic radioiodination ; Materials Science ; Nanoplatform ; Nanostructure ; Nanotechnology ; Radioactive tracers ; Theranostic ; Toxicity ; Tumor ; Tumors</subject><ispartof>Cancer nanotechnology, 2023-12, Vol.14 (1), p.6-17, Article 6</ispartof><rights>The Author(s) 2023</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</citedby><cites>FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2771822026/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2771822026?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,25732,27903,27904,36991,44569,74872</link.rule.ids></links><search><creatorcontrib>Swidan, Mohamed M.</creatorcontrib><creatorcontrib>Essa, Basma M.</creatorcontrib><creatorcontrib>Sakr, Tamer M.</creatorcontrib><title>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</title><title>Cancer nanotechnology</title><addtitle>Cancer Nano</addtitle><description>Background
Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe.
Results
Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior.
Conclusions
In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively.</description><subject>Biochemistry</subject><subject>Biocompatibility</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Cancer Research</subject><subject>Cerium gadolinium oxides</subject><subject>Chemistry and Materials Science</subject><subject>Comparative studies</subject><subject>Folic acid</subject><subject>Graphene</subject><subject>Graphene oxide nanosheets</subject><subject>In vivo methods and tests</subject><subject>Intrinsic radioiodination</subject><subject>Materials Science</subject><subject>Nanoplatform</subject><subject>Nanostructure</subject><subject>Nanotechnology</subject><subject>Radioactive tracers</subject><subject>Theranostic</subject><subject>Toxicity</subject><subject>Tumor</subject><subject>Tumors</subject><issn>1868-6958</issn><issn>1868-6966</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kc1u1TAQhSMEElXpC7CyxDpc_yROzA5VQCtVogtYW3Ptceqr1L7YzoX0MXhi3AaVHd6MNT7nm5FP07xl9D1jo9xlxmXXt5SLllLWD-36ojmrD2MrlZQvn-_9-Lq5yPlA6xFKKarOmt-3yefiA-5cnKFg65Zgio8BZv-AlkwJjncYkMRf3iKBTMrPSHwoyYfsDczzShJYH320PlSAJQFCbMsdplor2uQPJOPsdnaBuTrJyZ8iKZAmrHMnYuL9ERIUf0KSy2LXN80rB3PGi7_1vPn--dO3y6v25uuX68uPN60RvSqtACaNQqsGoToLIzjqOuHcSJVg46CoFGYvELjplVSd7KhhY8eBchiQgxDnzfXGtREO-pj8PaRVR_D6qRHTpCHV_WfUSo49690g9ig6CRTs0IGBXvZ7Y5h7ZL3bWMcUfyyYiz7EJdVPzJoPAxs5p1xWFd9UJsWcE7rnqYzqxyj1FqWuUeqnKPVaTWIz5SoOE6Z_6P-4_gAjGKWL</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Swidan, Mohamed M.</creator><creator>Essa, Basma M.</creator><creator>Sakr, Tamer M.</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><general>BMC</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0S</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>DOA</scope></search><sort><creationdate>20231201</creationdate><title>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</title><author>Swidan, Mohamed M. ; Essa, Basma M. ; Sakr, Tamer M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biochemistry</topic><topic>Biocompatibility</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Cancer Research</topic><topic>Cerium gadolinium oxides</topic><topic>Chemistry and Materials Science</topic><topic>Comparative studies</topic><topic>Folic acid</topic><topic>Graphene</topic><topic>Graphene oxide nanosheets</topic><topic>In vivo methods and tests</topic><topic>Intrinsic radioiodination</topic><topic>Materials Science</topic><topic>Nanoplatform</topic><topic>Nanostructure</topic><topic>Nanotechnology</topic><topic>Radioactive tracers</topic><topic>Theranostic</topic><topic>Toxicity</topic><topic>Tumor</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swidan, Mohamed M.</creatorcontrib><creatorcontrib>Essa, Basma M.</creatorcontrib><creatorcontrib>Sakr, Tamer M.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cancer nanotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swidan, Mohamed M.</au><au>Essa, Basma M.</au><au>Sakr, Tamer M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study</atitle><jtitle>Cancer nanotechnology</jtitle><stitle>Cancer Nano</stitle><date>2023-12-01</date><risdate>2023</risdate><volume>14</volume><issue>1</issue><spage>6</spage><epage>17</epage><pages>6-17</pages><artnum>6</artnum><issn>1868-6958</issn><eissn>1868-6966</eissn><abstract>Background
Nanomedicine offers great potentials for theranostic studies via providing higher efficacy and safety levels. This work aimed to develop and evaluate a new nanoplatform as a tumor theranostic probe.
Results
Carboxyl-functionalized graphene oxide nanosheets (FGO) was well synthesized from graphite powder and then conjugated with folic acid to act as a targeted nano-probe. Full characterization and in vitro cytotoxicity evaluation were conducted; besides, in vivo bio-evaluation was attained via intrinsic radioiodination approach in both normal and tumor-bearing Albino mice. The results indicated that FGO as well as conjugated graphene oxide nanosheets (CGO) are comparatively non-toxic to normal cells even at higher concentrations. Pharmacokinetics of FGO and CGO showed intensive and selective uptake in the tumor sites where CGO showed high T/NT of 7.27 that was 4 folds of FGO at 1 h post injection. Additionally, radioiodinated-CGO (ICGO) had declared a superior prominence over the previously published tumor targeted GO radiotracers regarding the physicochemical properties pertaining ability and tumor accumulation behavior.
Conclusions
In conclusion, ICGO can be used as a selective tumor targeting agent for cancer theranosis with aid of I-131 that has a maximum beta and gamma energies of 606.3 and 364.5 keV, respectively.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><doi>10.1186/s12645-023-00157-y</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1868-6958 |
ispartof | Cancer nanotechnology, 2023-12, Vol.14 (1), p.6-17, Article 6 |
issn | 1868-6958 1868-6966 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_968515f73be346a0ad74aca565bcc1f3 |
source | Publicly Available Content Database; Springer Nature - SpringerLink Journals - Fully Open Access |
subjects | Biochemistry Biocompatibility Biomedical Engineering and Bioengineering Cancer Research Cerium gadolinium oxides Chemistry and Materials Science Comparative studies Folic acid Graphene Graphene oxide nanosheets In vivo methods and tests Intrinsic radioiodination Materials Science Nanoplatform Nanostructure Nanotechnology Radioactive tracers Theranostic Toxicity Tumor Tumors |
title | Pristine/folate-functionalized graphene oxide as two intrinsically radioiodinated nano-theranostics: self/dual in vivo targeting comparative study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T00%3A04%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pristine/folate-functionalized%20graphene%20oxide%20as%20two%20intrinsically%20radioiodinated%20nano-theranostics:%20self/dual%20in%20vivo%20targeting%20comparative%20study&rft.jtitle=Cancer%20nanotechnology&rft.au=Swidan,%20Mohamed%20M.&rft.date=2023-12-01&rft.volume=14&rft.issue=1&rft.spage=6&rft.epage=17&rft.pages=6-17&rft.artnum=6&rft.issn=1868-6958&rft.eissn=1868-6966&rft_id=info:doi/10.1186/s12645-023-00157-y&rft_dat=%3Cproquest_doaj_%3E2771822026%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c359t-3a16c9ed97394da8af0f43ff80931879063cb3ea2c59694640c1842a02a7e2a33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2771822026&rft_id=info:pmid/&rfr_iscdi=true |